Saturna Capital Corp’s Astrazeneca PLC Position
Does Saturna Capital Corp own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 1.64M shares worth $150M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$150M
Q4 2025
Shares
1.64M
% of Portfolio
+1.99%
Quarters Held
16
position exited
Position History AZNN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 1.64M | $150M | +1.99% |
| Q3 2025 | 1.63M | $125M | +1.62% |
| Q2 2025 | 1.63M | $114M | +1.54% |
| Q1 2025 | 1.64M | $120M | +1.80% |
| Q4 2024 | 1.64M | $107M | +1.46% |
| Q3 2024 | 1.67M | $130M | +1.71% |
| Q2 2024 | 1.67M | $130M | +1.73% |
| Q1 2024 | 1.67M | $113M | +1.56% |
| Q4 2023 | 1.27M | $86M | +1.34% |
| Q3 2023 | 1.07M | $73M | +1.29% |
| Q2 2023 | 1.08M | $77M | +1.33% |
| Q1 2023 | 1.07M | $74M | +1.44% |
| Q4 2022 | 1.07M | $72M | +1.56% |
| Q3 2022 | 1.04M | $57M | +1.40% |
| Q2 2022 | 793.7K | $52M | +1.24% |
| Q4 2018 | 6.0K | $228,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saturna Capital Corp’s full portfolio or all institutional holders of AZNN.